ArticleJournal of clinical medicine2024

Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study.

Tom Holvoet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.